Artemisia and the fight against Covid19

Advocacy for the implementation of clinical trials

Advocacy for the implementation of clinical trials of Artemisia herbal tea in the fight against Covid19

We have initiated a study and reflection group on care practices, research in phytotherapy, the links between conventional and traditional medicines and the recognition and structuration of the profession of traditional practitioner.

Within the framework of our activities, we supports advocacy and lobbying actions.

It is within this framework that we produce the «Advocacy for the implementation of clinical trials of Artemisia herbal tea in the fight against Covid19 in Rwanda», in collaboration with NGOs, researchers and doctors.

Abstact

Artemisia species, particularly Artemisia annua (the annual wormwood) and Artemisia afra (the African wormwood) are well known for their antimalarial properties, which have been extensively studied and validated by clinical trials.

Their antiviral properties have been less studied, but the studies published to date are promising.

They open up a line of research that should be encouraged in the current race against time to find a cure for the Covid19 pandemic.

The scientific studies already carried out on Artemisia species show :

⇒ the antiviral potential of the plant taken in the form of herbal tea or powder;

⇒ the antiviral potential of some of its compounds: phytosterols, quercetin, luteolin, β-sitosterol, stigmasterol and tannins;

⇒ the synergy of these compounds when the extract of the totum of the foliar parts of the plant is administered;

⇒ the immunostimulatory potential of the plant;

⇒ the efficacy of administering medicinal decoctions including Artemisia annua in addition to conventional treatments to alleviate symptoms;

⇒ the absence of toxicity of the infusion or powder of the plant.

Considering on the one hand that cases, to date anecdotal but increasing in number, suggest that taking Artemisia annua herbal tea has had a curative effect on patients infected with Covid19 and that other cases tend to show that it would also have a preventive effect ;

considering, on the other hand, the current lack of available treatment for the deleterious effects of Covid19 ;

considering, finally, the availability of the resource in Rwanda, and the presence of researchers who have studied the plant and its properties ;

we believe that the conduct of clinical trials based on the taking of Artemisia annua and afra herbal tea should be very quickly encouraged, as the taking of Artemisia annua or afra herbal tea as a preventive measure, especially for particularly exposed persons such as health care personnel.

Covid19 - Advocacy for the implementation of clinical trials of Artemisia
Covid19 - Advocacy for the implementation of clinical trials of Artemisia [EN]
English
Covid19: Plaidoyer pour la mise en œuvre d’essais cliniques d’Artemisia
Plaidoyer pour la mise en œuvre d’essais cliniques de la tisane d’Artemisia dans le cadre de la lutte contre le Covid19
Version française

Assessing the potential of Artemisia annua in the fight (...)

Assessing the potential of Artemisia annua in the fight against COVID-19

Artemisia Annua, EMMPRIN, CYP A, PAK 1 et les métalloprotéases

Artemisia Annua, EMMPRIN, CYP A, PAK 1 et les métalloprotéases

Transmembrane Serine Protease and Anti-Androgen Receptor (...)

Transmembrane Serine Protease and Anti-Androgen Receptor Activity of Artemisia annua: another therapeutic option for COVID-19

Action of Artemisia annua on adaptive immunity in COVID-19 (...)

Action of Artemisia annua on adaptive immunity in COVID-19 infections

Websites

Africa CDC
Africa CDC    
Africa COVID-19 (TGHN)
Africa COVID-19 (TGHN)    
ALERRT
ALERRT    
Artemisia
Artemisia    
ASLM
ASLM    
CANTAM
CANTAM    
 Inter-Culturel | 2019 · 2021